Author Question: A 59-year-old COPD patient comes to the hospital with upper abdominal surgery. The physician ... (Read 148 times)

Collmarie

  • Hero Member
  • *****
  • Posts: 569
A 59-year-old COPD patient comes to the hospital with upper abdominal surgery. The physician diagnoses the patient with pulmonary atelectasis. The patient has a vital capacity of 25 ml/kg.
 
  Which of the following lung expansion therapy will you recommend to assist this patient's ate-lectasis?
  a. Incentive spirometry
  b. IPPB
  c. CPAP
  d. EPAP

Question 2

Which of the following are potential complications of continuous positive airway pressure (CPAP) therapy? 1. Barotrauma 2. Hyperventilation 3. Gastric distention 4. Hypercapnia
 
  a. 1 and 3 only
  b. 2 and 3 only
  c. 1, 3, and 4 only
  d. 2, 3, and 4 only



gstein359

  • Sr. Member
  • ****
  • Posts: 293
Answer to Question 1

ANS: A

Answer to Question 2

ANS: A
The increased work of breathing caused by the apparatus can lead to hypoventilation and hyper-capnia. In addition, because CPAP does not augment spontaneous ventilation, patients with an accompanying ventilatory insufficiency may hypoventilate during application. Barotrauma is a potential hazard of CPAP and is more likely to occur in the patient with emphysema and blebs. Gastric distention may occur, especially if CPAP pressures above 15 cm H2O are needed.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Lower drug doses for elderly patients should be used first, with titrations of the dose as tolerated to prevent unwanted drug-related pharmacodynamic effects.

Did you know?

One way to reduce acid reflux is to lose two or three pounds. Most people lose weight in the belly area first when they increase exercise, meaning that heartburn can be reduced quickly by this method.

Did you know?

The term pharmacology is derived from the Greek words pharmakon("claim, medicine, poison, or remedy") and logos ("study").

Did you know?

Fatal fungal infections may be able to resist newer antifungal drugs. Globally, fungal infections are often fatal due to the lack of access to multiple antifungals, which may be required to be utilized in combination. Single antifungals may not be enough to stop a fungal infection from causing the death of a patient.

Did you know?

In Eastern Europe and Russia, interferon is administered intranasally in varied doses for the common cold and influenza. It is claimed that this treatment can lower the risk of infection by as much as 60–70%.

For a complete list of videos, visit our video library